At the height of the COVID-19 pandemic, thousands of clinical trials were either suspended or stopped all together due to safety concerns or regional lockdown conditions.
The DIA 2021 virtual global annual meeting in June brought together many key opinion leaders, researchers, and partners across the industry to discuss how they leveraged novel processes and technologies to continue their work during this challenging time.
How did the industry come together to leverage new processes and innovative technologies to overcome the challenges posed by the pandemic? What new opportunities were discovered that can address long standing challenges in clinical research? What’s next as we move forward and apply our key learnings from the pandemic?
Our latest blog shares perspectives on DIA 2021 and our key takeaways from the meeting.